Abstract
Advances in gene profiling technology have led to the identification of novel gene expression signatures and individual biomarkers associated with the cancer and the spread of malignancy to distant organs. Molecular imaging is a very promising technology which provides the potential for utilizing these biomarkers for monitoring tumor progression and therapeutic response. This technology may allow real-time, dynamic, and quantifiable monitoring of biomarker activity. This chapter describes molecular imaging modalities that are currently available for monitoring clinical and experimental metastasis, their application and potential to monitor tumor progression and therapeutic outcome of a treatment regimen in real time, and in the discovery and development of novel drugs that target metastatic disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cady, B. Regional lymph node metastases; a singular manifestation of the process of clinical metastases in cancer: contemporary animal research and clinical reports suggest unifying concepts. Ann Surg Oncol 14: 1790–800, 2007.
Leong, S.P., B. Cady, D.M. Jablons, J. Garcia-Aguilar, D. Reintgen, J. Jakub, S. Pendas, L. Duhaime, R. Cassell, M. Gardner, R. Giuliano, V. Archie, D. Calvin, L. Mensha, S. Shivers, C. Cox, J.A. Werner, Y. Kitagawa, and M. Kitajima. Clinical patterns of metastasis. Cancer Metastasis Rev 25: 221–32, 2006.
Leong, S.P., B. Cady, D.M. Jablons, J. Garcia-Aguilar, D. Reintgen, J.A. Werner, and Y. Kitagawa. Patterns of metastasis in human solid cancers. Cancer Treat Res 135: 209–21, 2007.
Vicent, S., D. Luis-Ravelo, I. Anton, I. Garcia-Tunon, F. Borras-Cuesta, J. Dotor, J. De Las Rivas, and F. Lecanda. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res 68: 2275–85, 2008.
Inamura, K., T. Shimoji, H. Ninomiya, M. Hiramatsu, M. Okui, Y. Satoh, S. Okumura, K. Nakagawa, T. Noda, M. Fukayama, and Y. Ishikawa. A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity. Hum Pathol 38: 702–9, 2007.
Montel, V., T.Y. Huang, E. Mose, K. Pestonjamasp, and D. Tarin. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Pathol 166: 1565–79, 2005.
Hu, J., F. Bianchi, M. Ferguson, A. Cesario, S. Margaritora, P. Granone, P. Goldstraw, M. Tetlow, C. Ratcliffe, A.G. Nicholson, A. Harris, K. Gatter, and F. Pezzella. Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene 24: 1212–9, 2005.
Li, C., Z. Chen, Z. Xiao, X. Wu, X. Zhan, X. Zhang, M. Li, J. Li, X. Feng, S. Liang, P. Chen, and J.Y. Xie. Comparative proteomics analysis of human lung squamous carcinoma. Biochem Biophys Res Commun 309: 253–60, 2003.
Yanagisawa, K., B.J. Xu, D.P. Carbone, and R.M. Caprioli. Molecular fingerprinting in human lung cancer. Clin Lung Cancer 5: 113–8, 2003.
Sharma, V., G.D. Luker, and D. Piwnica-Worms. Molecular imaging of gene expression and protein function in vivo with PET and SPECT. J Magn Reson Imaging 16: 336–51, 2002.
Contag, C.H. and M.H. Bachmann. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4: 235–60, 2002.
Weissleder, R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2: 11–8, 2002.
Blasberg, R.G. Molecular imaging and cancer. Mol Cancer Ther 2: 335–43, 2003.
Gelovani Tjuvajev, J. and R.G. Blasberg. In vivo imaging of molecular-genetic targets for cancer therapy. Cancer Cell 3: 327–32, 2003.
Herschman, H.R. Molecular imaging: looking at problems, seeing solutions. Science 302: 605–8, 2003.
Gross, S. and D. Piwnica-Worms. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7: 5–15, 2005.
Jaffer, F.A. and R. Weissleder. Molecular imaging in the clinical arena. Jama 293: 855–62, 2005.
Weissleder, R. and U. Mahmood. Molecular imaging. Radiology 219: 316–33, 2001.
Weissleder, R. and V. Ntziachristos. Shedding light onto live molecular targets. Nat Med 9: 123–8, 2003.
Mahmood, U. and R. Weissleder. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2: 489–96, 2003.
Chenevert, T.L., L.D. Stegman, J.M. Taylor, P.L. Robertson, H.S. Greenberg, A. Rehemtulla, and B.D. Ross. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92: 2029–36, 2000.
Moffat, B.A., D.E. Hall, J. Stojanovska, P.J. McConville, J.B. Moody, T.L. Chenevert, A. Rehemtulla, and B.D. Ross. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. Magma 17: 249–59, 2004.
Guccione, S., K.C. Li, and M.D. Bednarski. Molecular imaging and therapy directed at the neovasculature in pathologies. How imaging can be incorporated into vascular-targeted delivery systems to generate active therapeutic agents. IEEE Eng Med Biol Mag 23: 50–6, 2004.
Morgan, B., M.A. Horsfield, and W.P. Steward. The role of imaging in the clinical development of antiangiogenic agents. Hematol Oncol Clin North Am 18: 1183–206, x, 2004.
Louie, A.Y., M.M. Huber, E.T. Ahrens, U. Rothbacher, R. Moats, R.E. Jacobs, S.E. Fraser, and T.J. Meade. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18: 321–5, 2000.
Ntziachristos, V., C. Bremer, E.E. Graves, J. Ripoll, and R. Weissleder. In vivo tomographic imaging of near-infrared fluorescent probes. Mol Imaging 1: 82–8, 2002.
Bremer, C., V. Ntziachristos, and R. Weissleder. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 13: 231–43, 2003.
Funovics, M., R. Weissleder, and C.H. Tung. Protease sensors for bioimaging. Anal Bioanal Chem 377: 956–63, 2003.
Ntziachristos, V., E.A. Schellenberger, J. Ripoll, D. Yessayan, E. Graves, A. Bogdanov, Jr., L. Josephson, and R. Weissleder. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci USA 101: 12294–9, 2004.
Dzik-Jurasz, A.S. Molecular imaging in vivo: an introduction. Br J Radiol 76 Spec No 2: S98–109, 2003.
Bhojani, M.S., B. Laxman, B.D. Ross, and A. Rehemtulla. Molecular imaging in cancer. In Apoptosis and Cancer Therapy, K.-M. Debatin and S. Fulda, eds. (Weinheim: Wiley-VCH, 2006).
Buchsbaum, D., R. Lloyd, J. Juni, I. Wollner, P. Brubaker, D. Hanna, J. Spicker, F. Burns, Z. Steplewski, D. Colcher et al. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice. Cancer Res 48: 4324–33, 1988.
Buchsbaum, D.J. Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs. Semin Nucl Med 34: 32–46, 2004.
Figueiredo, J.L., H. Alencar, R. Weissleder, and U. Mahmood. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 118: 2672–7, 2006.
Blum, G., G. von Degenfeld, M.J. Merchant, H.M. Blau, and M. Bogyo. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 3: 668–77, 2007.
Tung, C.H., U. Mahmood, S. Bredow, and R. Weissleder. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60: 4953–8, 2000.
Bremer, C., S. Bredow, U. Mahmood, R. Weissleder, and C.H. Tung. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology 221: 523–9, 2001.
Tung, C.H., S. Bredow, U. Mahmood, and R. Weissleder. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem 10: 892–6, 1999.
Rehemtulla, A., L.D. Stegman, S.J. Cardozo, S. Gupta, D.E. Hall, C.H. Contag, and B.D. Ross. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2: 491–5, 2000.
Ciana, P., M. Raviscioni, P. Mussi, E. Vegeto, I. Que, M.G. Parker, C. Lowik, and A. Maggi. In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9: 82–6, 2003.
Carlsen, H., J.O. Moskaug, S.H. Fromm, and R. Blomhoff. In vivo imaging of NF-kappa B activity. J Immunol 168: 1441–6, 2002.
Doubrovin, M., V. Ponomarev, T. Beresten, J. Balatoni, W. Bornmann, R. Finn, J. Humm, S. Larson, M. Sadelain, R. Blasberg, and J. Gelovani. Tjuvajev Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci USA 98: 9300–5, 2001.
Rehemtulla, A., N. Taneja, and B.D. Ross. Bioluminescence detection of cells having stabilized p53 in response to a genotoxic event. Mol Imaging 3: 63–8, 2004.
Laxman, B., D.E. Hall, M.S. Bhojani, D.A. Hamstra, T.L. Chenevert, B.D. Ross, and A. Rehemtulla. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 99: 16551–5, 2002.
Luker, G.D., V. Sharma, C.M. Pica, J.L. Prior, W. Li, and D. Piwnica-Worms. Molecular imaging of protein–protein interactions: controlled expression of p53 and large T-antigen fusion proteins in vivo. Cancer Res 63: 1780–8, 2003.
Massoud, T.F. and S.S. Gambhir. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17: 545–80, 2003.
Stell, A., S. Belcredito, B. Ramachandran, A. Biserni, G. Rando, P. Ciana, and A. Maggi. Multimodality imaging: novel pharmacological applications of reporter systems. Q J Nucl Med Mol Imaging 51: 127–38, 2007.
Ross, B.D., T.L. Chenevert, and A. Rehemtulla. Magnetic resonance imaging in cancer research. Eur J Cancer 38: 2147–56, 2002.
Rees, J. Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 16: 643–50, 2003.
Choy, G., P. Choyke, and S.K. Libutti. Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2: 303–12, 2003.
Bartrons, R. and J. Caro. Hypoxia, glucose metabolism and the Warburg’s effect. J Bioenerg Biomembr 39: 223–9, 2007.
Wallace, D.C. Mitochondria and cancer: Warburg addressed. Cold Spring Harb Symp Quant Biol 70: 363–74, 2005.
Massoud, T.F., R. Paulmurugan, and S.S. Gambhir. Molecular imaging of homodimeric protein–protein interactions in living subjects. Faseb J 18: 1105–7, 2004.
Blasberg, R.G. and J. Gelovani. Molecular-genetic imaging: a nuclear medicine-based perspective. Mol Imaging 1: 280–300, 2002.
Blankenberg, F.G., C. Mari, and H.W. Strauss. Development of radiocontrast agents for vascular imaging: progress to date. Am J Cardiovasc Drugs 2: 357–65, 2002.
McCaffrey, A., M.A. Kay, and C.H. Contag. Advancing molecular therapies through in vivo bioluminescent imaging. Mol Imaging 2: 75–86, 2003.
Greer, L.F., 3rd and A.A. Szalay. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 17: 43–74, 2002.
Mahmood, U. Near infrared optical applications in molecular imaging. Earlier, more accurate assessment of disease presence, disease course, and efficacy of disease treatment. IEEE Eng Med Biol Mag 23: 58–66, 2004.
Weissleder, R., C.H. Tung, U. Mahmood, and A. Bogdanov, Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17: 375–8, 1999.
Campbell, R.E., O. Tour, A.E. Palmer, P.A. Steinbach, G.S. Baird, D.A. Zacharias, and R.Y. Tsien. A monomeric red fluorescent protein. Proc Natl Acad Sci USA 99: 7877–82, 2002.
Shaner, N.C., R.E. Campbell, P.A. Steinbach, B.N. Giepmans, A.E. Palmer, and R.Y. Tsien. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22: 1567–72, 2004.
Zhang, H.G., J. Wang, X. Yang, H.C. Hsu, and J.D. Mountz. Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23: 2009–15, 2004.
Zipfel, W.R., R.M. Williams, R. Christie, A.Y. Nikitin, B.T. Hyman, and W.W. Webb. Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation. Proc Natl Acad Sci USA 100: 7075–80, 2003.
Zipfel, W.R., R.M. Williams, and W.W. Webb. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol 21: 1369–77, 2003.
Bhojani, M.S., G. Chen, B.D. Ross, D.G. Beer, and A. Rehemtulla. Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer. Cell Cycle 4: 1478–81, 2005.
Ntziachristos, V., C.H. Tung, C. Bremer, and R. Weissleder. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8: 757–60, 2002.
Messerli, S.M., S. Prabhakar, Y. Tang, K. Shah, M.L. Cortes, V. Murthy, R. Weissleder, X.O. Breakefield, and C.H. Tung. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6: 95–105, 2004.
Mahmood, U., C.H. Tung, A. Bogdanov, Jr., and R. Weissleder. Near-infrared optical imaging of protease activity for tumor detection. Radiology 213: 866–70, 1999.
Chen, J., C.H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M.C. Fishman, P.L. Huang, and R. Weissleder. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 105: 2766–71, 2002.
Parungo, C.P., S. Ohnishi, A.M. De Grand, R.G. Laurence, E.G. Soltesz, Y.L. Colson, P.M. Kang, T. Mihaljevic, L.H. Cohn, and J.V. Frangioni. In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. Ann Surg Oncol 11: 1085–92, 2004.
Parungo, C.P., S. Ohnishi, S.W. Kim, S. Kim, R.G. Laurence, E.G. Soltesz, F.Y. Chen, Y.L. Colson, L.H. Cohn, M.G. Bawendi, and J.V. Frangioni. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 129: 844–50, 2005.
Josephson, L., U. Mahmood, P. Wunderbaldinger, Y. Tang, and R. Weissleder. Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. Mol Imaging 2: 18–23, 2003.
Michalet, X., F.F. Pinaud, L.A. Bentolila, J.M. Tsay, S. Doose, J.J. Li, G. Sundaresan, A.M. Wu, S.S. Gambhir, and S. Weiss. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307: 538–44, 2005.
Gao, X., Y. Cui, R.M. Levenson, L.W. Chung, and S. Nie. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22: 969–76, 2004.
Lacoste, T.D., X. Michalet, F. Pinaud, D.S. Chemla, A.P. Alivisatos, and S. Weiss. Ultrahigh-resolution multicolor colocalization of single fluorescent probes. Proc Natl Acad Sci USA 97: 9461–6, 2000.
Dahan, M., S. Levi, C. Luccardini, P. Rostaing, B. Riveau, and A. Triller. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302: 442–5, 2003.
Hohng, S. and T. Ha. Near-complete suppression of quantum dot blinking in ambient conditions. J Am Chem Soc 126: 1324–5, 2004.
Ponomarev, V., M. Doubrovin, I. Serganova, J. Vider, A. Shavrin, T. Beresten, A. Ivanova, L. Ageyeva, V. Tourkova, J. Balatoni, W. Bornmann, R. Blasberg, and J. Gelovani. Tjuvajev A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 31: 740–51, 2004.
Doubrovin, M., I. Serganova, P. Mayer-Kuckuk, V. Ponomarev, and R.G. Blasberg. Multimodality in vivo molecular-genetic imaging. Bioconjug Chem 15: 1376–88, 2004.
Ray, P., A. De, J.J. Min, R.Y. Tsien, and S.S. Gambhir. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64: 1323–30, 2004.
Kim, Y.J., P. Dubey, P. Ray, S.S. Gambhir, and O.N. Witte. Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. Mol Imaging Biol 6: 331–40, 2004.
Yen, K.Y., J.A. Liang, A.C. Shiau, T.C. Hsieh, S.S. Sun, and C.H. Kao. Fusion images of Tl-201 SPECT and FDG PET with CT in detection of cervical carcinoma with bladder invasion. Clin Nucl Med 30: 278–80, 2005.
Blasberg, R.G. and J.G. Tjuvajev. Molecular-genetic imaging: current and future perspectives. J Clin Invest 111: 1620–9, 2003.
Schellenberger, E.A., D. Sosnovik, R. Weissleder, and L. Josephson. Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15: 1062–7, 2004.
Kerppola, T.K. Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol 7: 449–56, 2006.
Michnick, S.W., M.L. MacDonald, and J.K. Westwick. Chemical genetic strategies to delineate MAP kinase signaling pathways using protein-fragment complementation assays (PCA). Methods 40: 287–93, 2006.
Shyu, Y.J. and C.D. Hu. Fluorescence complementation: an emerging tool for biological research. Trends Biotechnol 26: 622–30, 2008.
Fields, S. and O. Song. A novel genetic system to detect protein–protein interactions. Nature 340: 245–6, 1989.
Michnick, S.W., P.H. Ear, E.N. Manderson, I. Remy, and E. Stefan. Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nat Rev Drug Discov 6: 569–82, 2007.
Paulmurugan, R. and S.S. Gambhir. Monitoring protein–protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation. Anal Chem 75: 1584–9, 2003.
Manning, G., G.D. Plowman, T. Hunter, and S. Sudarsanam. Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27: 514–20, 2002.
Manning, G., D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam. The protein kinase complement of the human genome. Science 298: 1912–34, 2002.
Edelman, A.M., D.K. Blumenthal, and E.G. Krebs. Protein serine/threonine kinases. Annu Rev Biochem 56: 567–613, 1987.
Hubbard, S.R. and J.H. Till. Protein tyrosine kinase structure and function. Annu Rev Biochem 69: 373–98, 2000.
Hunter, T. and J.A. Cooper. Protein-tyrosine kinases. Annu Rev Biochem 54: 897–930, 1985.
Tsygankov, A.Y. Non-receptor protein tyrosine kinases. Front Biosci 8: s595–635, 2003.
Zhang, L., M.S. Bhojani, B.D. Ross, and A. Rehemtulla. Molecular imaging of protein kinases. Cell Cycle 7: 314–7, 2008.
Blume-Jensen, P. and T. Hunter. Oncogenic kinase signalling. Nature 411: 355–65, 2001.
Zhang, L., K.C. Lee, M.S. Bhojani, A.P. Khan, A. Shilman, E.C. Holland, B.D. Ross, and A. Rehemtulla. Molecular imaging of Akt kinase activity. Nat Med 13: 1114–9, 2007.
Zhang, L., M.S. Bhojani, B.D. Ross, and A. Rehemtulla. Enhancing Akt imaging through targeted reporter expression. Mol Imaging 7: 168–74, 2008.
Zhou, V., X. Gao, S. Han, A. Brinker, J.S. Caldwell, and X.J. Gu. An intracellular conformational sensor assay for Abl T315I. Anal Biochem 385: 300–8, 2009.
Liotta, L.A., K. Tryggvason, S. Garbisa, I. Hart, C.M. Foltz, and S. Shafie. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–8, 1980.
Liotta, L.A., P.S. Steeg, and W.G. Stetler-Stevenson. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–36, 1991.
Coussens, L.M., B. Fingleton, and L.M. Matrisian. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387–92, 2002.
Stupack, D.G., T. Teitz, M.D. Potter, D. Mikolon, P.J. Houghton, V.J. Kidd, J.M. Lahti, and D.A. Cheresh. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439: 95–9, 2006.
Shi, Y. Apoptosome: the cellular engine for the activation of caspase-9. Structure 10: 285–8, 2002.
Nicholson, D.W. and N.A. Thornberry. Caspases: killer proteases. Trends Biochem Sci 22: 299–306, 1997.
Nicholson, D.W. and N.A. Thornberry. Apoptosis. Life and death decisions. Science 299: 214–5, 2003.
Bhojani, M.S., Ross, B.D., and A. Rehemtulla. TRAIL in Cancer Therapy. In Death Receptor in Cancer Therapy, El-Deiry, W.S., ed., Series Cancer Drug Discovery and Development (Totowa NJ: Humana, 2004).
Bhojani, M.S., B.D. Rossu, and A. Rehemtulla. TRAIL and anti-tumor responses. Cancer Biol Ther 2: S71–8, 2003.
Thormeyer, D., O. Ammerpohl, O. Larsson, Y. Xu, A. Asinger, C. Wahlestedt, and Z. Liang. Characterization of lacZ complementation deletions using membrane receptor dimerization. Biotechniques 34: 346–50, 352–5, 2003.
Zhang, G., X. Zhou, C. Wang, M. Yao, H. Yu, and Q. Xie. mRNA and protein expression of Fas associated death domain protein in apoptotic hepatocyte induced by tumor necrosis factor-alpha. Zhonghua Gan Zang Bing Za Zhi 9: 10–2, 2001.
Coppola, J.M., B.D. Ross, and A. Rehemtulla. Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clin Cancer Res 14: 2492–501, 2008.
Hu, C.D., Y. Chinenov, and T.K. Kerppola. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell 9: 789–98, 2002.
Luker, G.D., V. Sharma, C.M. Pica, J.L. Dahlheimer, W. Li, J. Ochesky, C.E. Ryan, H. Piwnica-Worms, and D. Piwnica.-Worms Noninvasive imaging of protein–protein interactions in living animals. Proc Natl Acad Sci USA 99: 6961–6, 2002.
Luker, K.E. and D. Piwnica-Worms. Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein–protein interactions in live cells and animals. Methods Enzymol 385: 349–60, 2004.
Galarneau, A., M. Primeau, L.E. Trudeau, and S.W. Michnick. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nat Biotechnol 20: 619–22, 2002.
Remy, I. and S.W. Michnick. A highly sensitive protein–protein interaction assay based on Gaussia luciferase. Nat Methods 3: 977–9, 2006.
Remy, I. and S.W. Michnick. Application of protein-fragment complementation assays in cell biology. Biotechniques 42: 137, 139, 141 passim, 2007.
Chenevert, T.L., C.R. Meyer, B.A. Moffat, A. Rehemtulla, S.K. Mukherji, S.S. Gebarski, D.J. Quint, P.L. Robertson, T.S. Lawrence, L. Junck, J.M. Taylor, T.D. Johnson, Q. Dong, K.M. Muraszko, J.A. Brunberg, and B.D. Ross. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 1: 336–43, 2002.
Moffat, B.A., T.L. Chenevert, T.S. Lawrence, C.R. Meyer, T.D. Johnson, Q. Dong, C. Tsien, S. Mukherji, D.J. Quint, S.S. Gebarski, P.L. Robertson, L.R. Junck, A. Rehemtulla, and B.D. Ross. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102: 5524–9, 2005.
Stroobants, S., J. Goeminne, M. Seegers, S. Dimitrijevic, P. Dupont, J. Nuyts, M. Martens, B. van den Borne, P. Cole, R. Sciot, H. Dumez, S. Silberman, L. Mortelmans, and A. van Oosterom. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 39: 2012–20, 2003.
Mankoff, D.A., A.F. Shields, and K.A. Krohn. PET imaging of cellular proliferation. Radiol Clin North Am 43: 153–67, 2005.
Blankenberg, F., K. Ohtsuki, and H.W. Strauss. Dying a thousand deaths. Radionuclide imaging of apoptosis. Q J Nucl Med 43: 170–6, 1999.
Luker, K.E., M.C. Smith, G.D. Luker, S.T. Gammon, H. Piwnica-Worms, and D. Piwnica-Worms. Kinetics of regulated protein–protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci USA 101: 12288–93, 2004.
Paulmurugan, R., Y. Umezawa, and S.S. Gambhir. Noninvasive imaging of protein–protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc Natl Acad Sci USA 99: 15608–13, 2002.
Luker, K.E., M. Gupta, and G.D. Luker. Imaging CXCR4 signaling with firefly luciferase complementation. Anal Chem 80: 5565–73, 2008.
Li, W.R., F. Li, Q. Huang, B. Frederick, S.D. Bao, and C.Y. Li. Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo. Cancer Res 68: 4990–4997, 2008.
Paulmurugan, R., T.F. Massoud, J. Huang, and S.S. Gambhir. Molecular imaging of drug-modulated protein–protein interactions in living subjects. Cancer Res 64: 2113–9, 2004.
Kaihara, A., Y. Umezawa, and T. Furukawa. Bioluminescent indicators for Ca2+ based on split renilla luciferase complementation in living cells. Analytical Sciences 24: 1405–8, 2008.
Chan, C.T., R. Paulmurugan, O.S. Gheysens, J. Kim, G. Chiosis, and S.S. Gambhir. Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects. Cancer Res 68: 216–226, 2008.
Cissell, K.A., Y. Rahimi, S. Shrestha, and S.K. Deo. Reassembly of a bioluminescent protein renilla luciferase directed through dna hybridization. Bioconjug Chem 2008.
Acknowledgments
We thank Terry Williams for critical reading of the manuscript. This work was supported by US National Institutes of Health grants P01CA85878, P50CA01014, R24CA83099, R01RCA129623A and a grant from the John and Suzanne Munn Endowed Research Fund of the University of Michigan Comprehensive Cancer Center (to MSB).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bhojani, M.S., Nyati, S., Rao, H.R., Ross, B.D., Rehemtulla, A. (2009). Molecular Imaging in Lung Cancer Metastases. In: Keshamouni, V., Arenberg, D., Kalemkerian, G. (eds) Lung Cancer Metastasis. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0772-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0772-1_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0771-4
Online ISBN: 978-1-4419-0772-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)